ACTGNetwork

RSS
Our International Vice Chair Dr. Ian Sanne spoke with the New York Times about how a cut in PEPFAR funding would affect his South African organization Right to Care and have a detrimental impact on people living with HIV.
#hiv #aids #southafrica #pepfar http://ift.tt/1qJVXlE

Our International Vice Chair Dr. Ian Sanne spoke with the New York Times about how a cut in PEPFAR funding would affect his South African organization Right to Care and have a detrimental impact on people living with HIV.
#hiv #aids #southafrica #pepfar http://ift.tt/1qJVXlE

Our International Vice Chair Dr. Ian Sanne spoke with the New York Times about how a cut in PEPFAR funding would affect his South African organization Right to Care and have a detrimental impact on people living with HIV.

Our International Vice Chair Dr. Ian Sanne spoke with the New York Times about how a cut in PEPFAR funding would affect his South African organization Right to Care and have a detrimental impact on people living with HIV.


Our fabulous Outreach, Recruitment and Retention subcommittee! They work at our sites around the world helping study teams create engaging study fliers and spearheading efforts to write notes of gratitude to study participants. Keep up this important work!!!
#actg2014 #hiv #aids #outreach http://ift.tt/1qJDVQw

Our fabulous Outreach, Recruitment and Retention subcommittee! They work at our sites around the world helping study teams create engaging study fliers and spearheading efforts to write notes of gratitude to study participants. Keep up this important work!!!
#actg2014 #hiv #aids #outreach http://ift.tt/1qJDVQw

Our fabulous Outreach, Recruitment and Retention subcommittee! They work at our sites around the world helping study teams create engaging study fliers and spearheading efforts to write notes of gratitude to study participants. Keep up this important work!!!

Our fabulous Outreach, Recruitment and Retention subcommittee! They work at our sites around the world helping study teams create engaging study fliers and spearheading efforts to write notes of gratitude to study participants. Keep up this important work!!!

(Source: actgnetwork.org)

AIDS Healthcare Foundation’s President Michael Weinstein doesn’t think people will take PrEP daily. Do you agree?
#hiv #aids #prep http://ift.tt/1ws0iT3

AIDS Healthcare Foundation’s President Michael Weinstein doesn’t think people will take PrEP daily. Do you agree?
#hiv #aids #prep http://ift.tt/1ws0iT3

AIDS Healthcare Foundation Launches Ad Campaign Against PrEP

AIDS Healthcare Foundation’s President Michael Weinstein doesn’t think people will adhere to PrEP’s daily dosing. Do you agree?

Meet EXA-MAN and GELLUX two sexual health super heroes who spread the word about HIV testing and PrEP in Lima, Peru. They are part of the educational outreach campaign at our IMPACTA Peru Clinical Trials site. Looking good!!!
#hiv #aids #actg2014 #peru #prep #gettested #knowyourstatus http://ift.tt/1tshKlB

Meet EXA-MAN and GELLUX two sexual health super heroes who spread the word about HIV testing and PrEP in Lima, Peru. They are part of the educational outreach campaign at our IMPACTA Peru Clinical Trials site. Looking good!!!
#hiv #aids #actg2014 #peru #prep #gettested #knowyourstatus http://ift.tt/1tshKlB

Meet EXA-MAN and GELLUX two sexual health super heroes who spread the word about HIV testing and PrEP in Lima, Peru. They are part of the educational outreach campaign at our IMPACTA Peru Clinical Trials site. Looking good!!!

Meet EXA-MAN and GELLUX two sexual health super heroes who spread the word about HIV testing and PrEP in Lima, Peru. They are part of the educational outreach campaign at our IMPACTA Peru Clinical Trials site. Looking good!!!

(Source: impactaperu.org)

Our Dr. Sally Hodder leads our New Jersey Medical School site. She and her team have been implementing innovative ways to keep their patients adherent to their HIV medications including using case managers and better tolerated drugs. This is important work as the CDC estimates only 50 percent of people living with HIV are engaged in care and only 25 percent have their viral load suppressed. Click here to read more about Sally and her research!

Our Dr. Sally Hodder leads our New Jersey Medical School site. She and her team have been implementing innovative ways to keep their patients adherent to their HIV medications including using case managers and better tolerated drugs. This is important work as the CDC estimates only 50 percent of people living with HIV are engaged in care and only 25 percent have their viral load suppressed. Click here to read more about Sally and her research!

Our Dr. Sally Hodder leads our New Jersey Medical School site. She and her team have been implementing innovative ways to keep their patients adherent to their HIV medications including using case managers and better tolerated drugs. This is important work as the CDC estimates only 50 percent of people living with HIV are engaged in care and only 25 percent have their viral load suppressed. Read more about Sally and her research on our website actgnetwork.org
#hiv #aids #newjersey http://ift.tt/1toPjF8

Our Dr. Sally Hodder leads our New Jersey Medical School site. She and her team have been implementing innovative ways to keep their patients adherent to their HIV medications including using case managers and better tolerated drugs. This is important work as the CDC estimates only 50 percent of people living with HIV are engaged in care and only 25 percent have their viral load suppressed. Read more about Sally and her research on our website actgnetwork.org
#hiv #aids #newjersey http://ift.tt/1toPjF8